Recent knowledges on the linkage of strain specific genotypes with clinical manifestations of human citomegalovirus disease;Attuali conoscenze sulla variabilità genetica del citomegalovirus umano e sua correlazione con il potenziale patogeno del virus: Implicazioni diagnostico-terapeutiche

Recenti Progressi in Medicina

Volumn 102, Issue 1, 2011, Pages 5-10

  Pignatelli, Sara ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Clinical isolates; Congenital infection; Gene polymorphisms; Human cytomegalovirus; Viral genotypes as prognostic markers; Wild type strains

Indexed keywords

CLINICAL FEATURE; CYTOMEGALOVIRUS INFECTION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; IMMUNOCOMPROMISED PATIENT; IMMUNOPATHOGENESIS; NOTE; PROGNOSIS; VIRUS STRAIN;

CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; GENOTYPE; HUMANS; POLYMORPHISM, GENETIC;

EID: 79951542934     PISSN: 00341193     EISSN: 20381840     Source Type: Journal    
DOI: 10.1701/545.6466     Document Type: Note

References (54)

1. Ho M. Epidemiology of cytomegalovirus infections. Rev Infect Dis 1990; 12: S701.
2. Mocarski ES. Cytomegaloviruses and their replication. In: Fields BH, Knipe DM, Howley PM, et al. (eds). Virology, 4rd ed 2000. Lippincott-Raven, Philadelphia, PA.
3. Gaytant MA, Steegers EA, Semmekrot BA, Merkus HM, Galama JM. Congenital cytomegalovirus infection: review of the epidemiology and outcome. Obstet Gynecol Surv 2002; 57: 245-56. (Pubitemid 34407101)
4. Huang ES, Kilpatrick BA, Huang YT, Pagano JS. Detection of human cytomegalovirus and analysis of strain variation. Yale J Biol Med 1976; 49: 29-43.
5. Chou S, Erice A, Jordan MC, et al. Analysis of the UL97 phosphotransferase coding sequence in clinical cytomegalovirus isolates and identification of mutations conferring ganciclovir resistance. J Infect Dis 1995; 171: 576-83.
6. Alejo E. Resistance of human cytomegalovirus to antiviral drugs. Clin Microbiol Rev 1999; 12: 286-97.
7. Lurain NS, Chou S. Antiviral drug resistance of human cytomegalovirus. Clin Microbiol Rev 2010; 23: 689-712.
8. Pignatelli S, Dal Monte P, Rossini G, Landini MP. Genetic polymorphisms among human cytomegalovirus (HCMV) wild-type strains. Rev Med Virol 2004; 14: 383-410. (Pubitemid 39487680)
9. Navarro D, Paz P, Tugizov S, Topp K, La Vail J, Pereira L. Glycoprotein B of human cytomegalovirus promotes virion penetration into cells, transmission of infection from cell to cell, and fusion of infected cells. Virol 1993; 197: 143-58.
10. Chou S, Dennison KM. Analysis of interstrain variation in cytomegalovirus glycoprotein B sequences encoding neutralization-related epitopes. J Infect Dis 1991; 163: 1229-34.
11. Trincado DE, Scott GM, White PA, Hunt C, Rasmussen L, Rawlison WD. Human cytomegalovirus strain associated with congenital and perinatal infections. J Med Virol 2000; 61: 481-7. (Pubitemid 30450690)
12. Lurain NS, Kapell KS, Huang DD, et al. Human cytomegalovirus UL144 open reading frame sequence hypervariability in low-passage clinical isolates. J Virol 1999; 73: 10040-50.
13. Arav-Boger R, Willoughby RE, Pass RF, et al. Polymorphisms of the cytomegalovirus (CMV)-encoded tumor necrosis factor-alpha and beta-chemokine receptors in congenital CMV disease. J Infect Dis 2002; 186: 1057-64. (Pubitemid 35177106)
14. Bale JF jr, Petheram SJ, Robertson M, Murph JR, Demmler G. Human cytomegalovirus a sequence and UL144 variability in strains from infected children. J Med Virol 2001; 65: 933-6.
15. Paterson DA, Dyer AP, Milne RS, Sevilla-Reyes E, Gompels UA. A role for human cytomegalovirus glycoprotein O (gO) in cell fusion and a new hypervariable locus. Virology 2002; 293: 281-94.
16. Rasmussen L, Geissler A, Cowan C, Chase A, Winters M. The genes encoding the gCIII complex of human cytomegalovirus exist in highly diverse combinations in clinical isolates. J Virol 2002; 76: 10841-8. (Pubitemid 35176201)
17. Kari B & Gehrz R. Structure, composition and heparin binding properties of a human cytomegalovirus glycoprotein complex designed gC-II. J Gen Virol 1993; 74: 225-64.
18. Mach M, Kropff B, Dal Monte P, Britt WJ. Complex formation of human cytomegalovirus glycoprotein M (gpUL100) and glycoprotein N (gpUL73). J Virol 2000; 74: 11881-92. (Pubitemid 32222338)
19. Dal Monte P, Pignatelli S, Mach M Landini MP. The product of human cytomegalovirus UL73 is a new polymorphic structutal glycoprotein (gpUL73). J Hum Virol 2001; 4: 26-33.
20. Burkhardt C, Himmelein S, Britt W, Winkler T, Mach M. Glycoprotein N subtypes of human cytomegalovirus induce a strain-specific antibody response during natural infection. J Gen Virol 2009; 90: 1951-61.
21. Pignatelli S, Dal Monte P, Landini MP. gpUL73(gN) genomic variants of human cytomegalovirus (HCMV) isolates are clustered into four distinct genotypes. J Gen Virol 2001; 82: 2777-84. (Pubitemid 32998655)
22. Pignatelli S, Dal Monte P, Rossini G. Human cytomegalovirus glycoprotein N (gpUL73) genomic variants: identification of a novel subgroup, geographical distribution and evidence of positive selective pressure. J Gen Virol 2003; 84 : 647-55. (Pubitemid 36267139)
23. Mattick C, Dewin D, Polley S, et al. Linkage of human cytomegalovirus glycoprotein gO variant groups identified from worldwide clinical isolates with gN genotypes, implications for disease associations and evidence for N-terminal sites of positive selection. Virology 2004; 318: 582-97. (Pubitemid 38224301)
24. Yan H, Koyano S, Inami Y, et al. Genetic linkage among human cytomegalovirus glycoprotein N (gN) and gO genes, with evidence for recombination from congenitally and post-natally infected Japanese infants. J Gen Virol 2008; 89: 2275-9.
25. Bates M, Monze M, Bima H, et al. CIGNIS study group. High human cytomegalovirus loads and diverse linked variable genotypes in both HIV-1 infected and exposed, but uninfected, children in Africa. Virology 2008; 382: 28-36.
26. Rasmussen L, Hong C, Zipeto D, et al. Cytomegalovirus gB genotype distribution differs in human immunodeficiency virus-infected patients and immunocompromised allograft recipients. J Infect Dis 1997; 175: 179-84. (Pubitemid 27020844)
27. Bale JF, Murph JR, Demmler GJ, Dawson J, Miller JE, Petheram SJ. Intrauterine cytomegalovirus infection and glycoprotein B genotypes. J Infect Dis 2000; 182: 933-6.
28. Haberland M, Meyer-Konig U, Hufert FT. Variation within the glycoprotein B gene of human cytomegalovirus is due to homologous recombination. J Gen Virol 1999; 80: 1495-500. (Pubitemid 29261481)
29. Aquino VH, Figueiredo LT. High prevalence of renal transplant recipients infected with more than one cytomegalovirus glycoprotein B genotype. J Med Virol 2000; 61: 138-42. (Pubitemid 30191239)
30. Fidouh-Houhou N, Duval X, Bissuel F. Salivary cytomegalovirus (CMV) shedding, glycoprotein B genotype distribution, and CMV disease in human immunodeficiency virus-seropositive patients. Clin Infect Dis 2001; 33: 1406-11. (Pubitemid 32955196)
31. Drew WL, Chou S, Miner RC. Cytomegalovirus glycoprotein B groups in human immunodeficiency virus-infected patients with incident retinitis. J Infect Dis 2002; 186: 114-7. (Pubitemid 34666923)
32. Shepp DH, Match ME, Ashraf AB, Lipson SM, Millan C, Pergolizzi R. Cytomegalovirus glycoprotein B groups associated with retinitis in AIDS. J Inf Dis 1998; 174: 184-7.
33. Goossens VJ, Wolffs PF, van Loo IH, Bruggeman CA, Verbon A. CMV DNA levels and CMV gB subtypes in ART-naive HAART-treated patients: a 2-year follow-up study in the Netherlands. AIDS 2009; 23: 1425-9.
34. Pignatelli S, Dal Monte P, Rossini G, Gatto MR, Landini MP. Human cytomegalovirus glycoprotein N (gN) genotypes in AIDS patients. AIDS 2003a; 17: 761-3. (Pubitemid 36521086)
35. Vogelberg C, Meyer-Koning U, Hufert FT, Kirste G, von Laer D. Human cytomegalovirus glycoprotein B in renal trasplant recipients. J Med Virol 1996; 50: 31-4. (Pubitemid 26348940)
36. Sarcinella L, Mazzulli T, Willey B, Humar A. Cytomegalovirus glycoprotein B genotype does not correlate with outcomes in liver transplant patients. J Clin Virol 2002; 24: 99-105. (Pubitemid 34016019)
37. Mewara A, Mishra B, Ratho RK, Kumar P. Cytomegalovirus glycoprotein B gene polymorphism and its association with clinical presentations in infants. Southeast Asian J Trop Med Public Health 2009; 40: 759-64.
38. Nogueira E, Ozaki KS, Tomiyama H, Câmara NO, Granato CF. Clinical correlations of human cytomegalovirus strains and viral load in kidney transplant recipients. Int Immunopharmacol 2009; 9: 26-31.
39. Fries BC, Chou S, Boeckh M, Torok-Storb. Frequency distribution of cytomegalovirus envelope glycoprotein genotypes in bone marrow transplant recipiens. J Infect Dis 1994; 169: 769-74. (Pubitemid 24102108)
40. Roubalová K, Strunecký O, Zufanová S, Procházka B, Vitek A. [Genotyping of viral glycoprotein B (gB) in hematopoietic stem cell transplant recipients with active cytomegalovirus infection: analysis of the impact of gB genotypes on the patients' outcome] Epidemiol Mikrobiol Imunol 2010; 59: 92-9.
41. Woo PC, Lo CY, Lo SK, et al. Distinct genotypic distributions of cytomegalovirus (CMV) envelope glycoprotein in bone marrow and renal transplant recipients with CMV disease. Clin Diagn Lab Immunol 1997; 4: 515-8. (Pubitemid 27448614)
42. Wu X, Wang Y, Xu Y, et al. Cytomegalovirus glycoprotein B genotype in hematopoietic stem cell transplant patients from China. Biol Blood Marrow Transplant 2010; 16: 647-52.
43. Rossini G, Pignatelli S, Dal Monte P, et al. Monitoring for human cytomegalovirus infection in solid organ transplant recipients through antigenemia and glycoprotein N (gN) variants: evidence of correlation and potential prognostic value of gN genotypes. Microbes Infect 2005; 7: 890-6. (Pubitemid 40826656)
44. Barbi M, Binda S, Caroppo S, et al. CMV gB genotypes and outcome of vertical transmission: study on dried blood spots of congenitally infected babies. J Clin Virol 2001; 21: 75-9.
45. Lukacsi A, Taroldi B, Endreffy E, Babinszki A, Pa A, Pusztai R. Human cytomegalovirus gB genotype 1 is dominant in congenital infections in South Hungary. J Med Virol 2001; 65: 537-42. (Pubitemid 32959082)
46. Arav-Boger R, Battaglia CA, Lazzarotto T, et al. Cytomegalovirus (CMV)-encoded UL144 (truncated tumor necrosis factor receptor) and outcome of congenital CMV infection. J Infect Dis 2006; 194: 464-73. (Pubitemid 44162657)
47. Waters A, Hassan J, Degascun C, et al. Human cytomegalovirus UL144 is associated with viremia and infant development in congenital infection. J Clin Microbiol 2010 [Epub ahead of print].
48. Picone O, Costa JM, Chaix ML, Ville Y, Rouzioux C, Leruez-Ville M. Human cytomegalovirus UL144 gene polymorphisms in congenital infections. J Clin Microbiol 2005; 43: 25-9. (Pubitemid 40096275)
49. Mao ZQ, He R, Sun M, Qi Y, Huang YJ, Ruan Q. The relationship between polymorphisms of HCMV UL144 ORF and clinical manifestations in 73 strains with congenital and/or perinatal HCMV infection. Arch Virol 2007; 152: 115-24. (Pubitemid 44974619)
50. Heo J, Petheram S, Demmler G, Murph JR, Adler SP, Bale J, Sparer TE. Polymorphisms within human cytomegalovirus chemokine (UL146/UL147) and cytokine receptor genes (UL144) are not predictive of sequelae in congenitally infected children. Virology 2008; 378: 86-96.
51. Pignatelli S, Dal Monte P, Rossini G, Lazzarotto T, Gatto MR, Landini MP. Intrauterine cytomegalovirus infection and glycoprotein N (gN) genotypes. J Clin Virol 2003b; 28: 38-43. (Pubitemid 36970102)
52. Pignatelli S, Lazzarotto T, Gatto MR, et al. Cytomegalovirus gN genotypes distribution among congenitally infected newborns and their relationship with symptoms at birth and sequelae. Clin Infect Dis 2010; 51: 33-41.
53. Adler SP. Human CMV vaccine trials: what if CMV caused a rash? J Clin Virol 2008; 41: 231-6.
54. Schleiss MR. Cytomegalovirus vaccine development. Curr Top Microbiol Immunol 2008; 325: 361-82.